Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3521 Target Snapshot

Receptor-type tyrosine-protein phosphatase F · SINGLE PROTEIN · Homo sapiens

638Compounds
130Assays
0Approved Drugs
430.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P10586. Use UniProt P10586 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P10586 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Receptor-type tyrosine-protein phosphatase F as ChEMBL target CHEMBL3521, mapped to UniProt P10586. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Receptor-type tyrosine-protein phosphatase F
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3521
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P10586
Receptor-type tyrosine-protein phosphatase F
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Receptor-type tyrosine-protein phosphatase F is the right protein anchor across sources, using UniProt P10586 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelReceptor-type tyrosine-protein phosphatase F
UniProt AccessionP10586
Component TypeProtein
Sequence Length1907 aa

Receptor-type tyrosine-protein phosphatase F

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Receptor-type tyrosine-protein phosphatase F, mapped to UniProt P10586. Sequence length is 1907 aa.

Mapped IDP10586
Review nameReceptor-type tyrosine-protein phosphatase F
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC50363.0
KI67.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL506661 7.18 IC50 66.0 Preclinical
CHEMBL556636 6.42 IC50 382.3 Preclinical
CHEMBL564699 6.42 IC50 380.0 Preclinical
CHEMBL1241315 6.39 IC50 410.0 Preclinical
CHEMBL324232 6.38 IC50 420.0 Preclinical
CHEMBL549372 6.34 IC50 458.3 Preclinical
CHEMBL556076 6.31 IC50 493.0 Preclinical
CHEMBL550662 6.2 IC50 624.7 Preclinical
CHEMBL200117 6.16 IC50 690.0 Preclinical
CHEMBL570779 6.12 IC50 765.3 Preclinical
Distribution

pChEMBL Value Distribution

27
5.0
22
5.5
9
6.0
0
6.5
1
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

135
Total Assays
128
Tested Compounds
2
Assay Types
Binding — 134 assays, 128 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 121 118 5.2
assay format 12 10 4.8
cell-based format 1 0
Functional — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine